Results 201 to 210 of about 44,269 (308)
Etiology, pathogenesis and treatment of peri‐implantitis: A European perspective
Abstract Peri‐implantitis is a plaque‐associated pathological condition occurring in tissues around dental implants. It is characterized by inflammation in the peri‐implant mucosa and progressive loss of supporting bone. Over the last 30 years, peri‐implantitis has become a major disease burden in dentistry.
Tord Berglundh +3 more
wiley +1 more source
Incidence and Characteristics of Perianal Infections in CPX-351-Treated AML Patients. [PDF]
Buzzatti E +14 more
europepmc +1 more source
Abstract The objective of the study was to assess the effect of soft‐tissue volume augmentation during early, delayed, and late dental implant therapy in terms of professionally determined esthetics and self‐reported patient satisfaction on esthetics. For this, a comprehensive electronic literature search was performed to identify randomized clinical ...
Ausra Ramanauskaite +5 more
wiley +1 more source
The Healing Effect of Aged Garlic Extract on Acetic Acid and 5-Fluorouracil-Induced Oral Mucositis in Mice. [PDF]
Kawasaki K +6 more
europepmc +1 more source
Engineered surface strategies to manage dental implant‐related infections
Abstract When exposed to the oral environment, dental implants, like natural surfaces, become substrates for microbial adhesion and accumulation, often leading to implant‐related infections—one of the main causes of implant failure. These failures impose significant costs on patients, clinicians, and healthcare systems.
João Gabriel S. Souza +7 more
wiley +1 more source
Lived experiences of chemotherapy-induced oral mucositis among patients with breast cancer: a phenomenological study. [PDF]
Ababneh A +5 more
europepmc +1 more source
Abstract Peri‐implant diseases are dysbiosis‐mediated inflammatory disorders that occur in susceptible hosts. Antimicrobials and immunomodulatory agents therefore might be pertinent as adjunctive measures in the treatment of such disorders. The aim of this narrative review was to examine the existing evidence and assess the effectiveness of emerging ...
Alberto Monje +3 more
wiley +1 more source
The Bi-steric, mTORC1-Selective Inhibitor, RMC-5552, in Advanced Solid Tumors: A Phase 1 Trial. [PDF]
Schram AM +19 more
europepmc +1 more source

